PMID- 36640479 OWN - NLM STAT- MEDLINE DCOM- 20230222 LR - 20240202 IS - 1872-6844 (Electronic) IS - 0920-1211 (Print) IS - 0920-1211 (Linking) VI - 190 DP - 2023 Feb TI - Reducing seizure to needle times in nonconvulsive status epilepticus with multifaceted quality improvement initiatives. PG - 107085 LID - S0920-1211(23)00010-4 [pii] LID - 10.1016/j.eplepsyres.2023.107085 [doi] AB - OBJECTIVES: Delayed management of nonconvulsive status epilepticus (NCSE) can lead to an increased morbidity and mortality. We previously established that inefficient treatment of NCSE at our institution stemmed from delayed initiation of emergent anti-seizure medications (ASM). In the present study, we assessed the trajectories of these time parameters and determined patient outcomes following the specific quality improvement (QI) interventions. METHODS: The QI interventions, including the revision of the educational content for trainees and pharmacy workflow optimization were implemented between January 2019 and September 2021 by a dedicated multidisciplinary task force. The times needed to initiate and administer the ASMs for patients with NCSE as well as patient mortality were assessed in comatose and noncomatose patients and compared with the corresponding values prior to the interventions. RESULTS: There were 79 occurrences of NCSE in 74 patients. The median time from seizure detection on EEG to the order of the first and second ASM for NCSE was reduced by 4 (p = 0.83) and 8 min (p = 0.52), respectively compared to the times prior to the initiation of interventions. The median times from the order to administration of the first and third ASM for all NCSE occurrences were reduced by 8 and 10 min, respectively (p = 0.28 and p = 0.10). In the present cohort of comatose patients, the median time spent to order the first ASM was reduced by 16.5 min and the time to administer it reduced by 35 min compared to that in our previous study. The overall patient mortality was decreased by 11.1%. SIGNIFICANCE: More efficient delivery of rescue ASMs in patients with NCSE and improvement in their mortality can be achieved with multidisciplinary team efforts aimed at streamlining the functioning of pharmacy and strengthening the education of trainees and nurses. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Gupta, Navnika AU - Gupta N AD - Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA. FAU - Baang, Hae Y AU - Baang HY AD - Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA. FAU - Barrett, Wattana AU - Barrett W AD - Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA. FAU - Reisbig, Katharine AU - Reisbig K AD - Acute Care Pharmacy, Nebraska Medicine Hospital, Omaha, NE, USA. FAU - Bendlin, Kayli A AU - Bendlin KA AD - Acute Care Pharmacy, Nebraska Medicine Hospital, Omaha, NE, USA. FAU - Coleman, Scott A AU - Coleman SA AD - Acute Care Pharmacy, Nebraska Medicine Hospital, Omaha, NE, USA. FAU - Samson, Kaeli AU - Samson K AD - Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA. FAU - Taraschenko, Olga AU - Taraschenko O AD - Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: olha.taraschenko@unmc.edu. LA - eng GR - P20 GM130447/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20230111 PL - Netherlands TA - Epilepsy Res JT - Epilepsy research JID - 8703089 SB - IM MH - Humans MH - *Coma/diagnosis MH - Quality Improvement MH - Electroencephalography MH - *Status Epilepticus/diagnosis MH - Cognition PMC - PMC9979156 MID - NIHMS1865142 OTO - NOTNLM OT - Anti-seizure medications OT - Medication delivery OT - Medication order set OT - Quality improvement OT - Resident education OT - Status epilepticus COIS- Disclosure of Conflict of Interest O.T. received salary and research support from the NIH P20GM130447 Cognitive NeuroScience and Development of Aging (CONDA) Award. All other authors report no disclosures. We confirm that we have read the journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. EDAT- 2023/01/15 06:00 MHDA- 2023/02/22 06:00 PMCR- 2024/02/01 CRDT- 2023/01/14 18:05 PHST- 2022/07/27 00:00 [received] PHST- 2023/01/05 00:00 [revised] PHST- 2023/01/09 00:00 [accepted] PHST- 2023/01/15 06:00 [pubmed] PHST- 2023/02/22 06:00 [medline] PHST- 2023/01/14 18:05 [entrez] PHST- 2024/02/01 00:00 [pmc-release] AID - S0920-1211(23)00010-4 [pii] AID - 10.1016/j.eplepsyres.2023.107085 [doi] PST - ppublish SO - Epilepsy Res. 2023 Feb;190:107085. doi: 10.1016/j.eplepsyres.2023.107085. Epub 2023 Jan 11.